Best Practice & Research Clinical Endocrinology & Metabolism
Volume 22, Issue 5 , Pages 765-785 , October 2008

Osteoporosis and osteoporotic fracture occurrence and prevention in the elderly: a geriatric perspective

  • Steven Boonen, MD, PhD (Professor of Geriatric Medicine; holder of the Leuven University Chair in Metabolic Bone Diseases, and senior clinical investigator of the Fund for Scientific Research-Flanders, Belgium)

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +32 16 34 26 48(direct line), +32 16 34 48 24(office).
  • Dirk Vanderschueren, MD, PhD (Professor of Medicine and senior clinical investigator of the Fund for Scientific Research-Flanders, Belgium)
    • ,
  • Katrien Venken (Postductoral Fellow of the Fund for Scientific Research–Flanders, Belgium)
  • Koen Milisen, RN, PhD (Associate Professor in Geriatric Nursing and Clinical Nurse Specialist)

References 

  1. Gehlbach SH, Avrunin JS, Puleo E, et al. Fracture risk and antiresorptive medication use in older women in the USA. Osteoporosis International. 2007;18:805–810
  2. Melton LJ, Thamer M, Ray NF, et al. Factors attributable to osteoporosis. Report from the National Osteoporosis Foundation. Journal of Bone and Mineral Research. 1997;12:16–23
  3. O'Neill TW, Felsenberg D, Varlow J, et al. The prevalence of vertebral deformity in European men and women: The European Vertebral Osteoporosis Study. Journal of Bone and Mineral Research. 1996;11:1010–1018
  4. Seeman E, Vellas B, Benhamou CL, et al. Strontium ranelate reduces the risk of vertebral and non-vertebral fractures in women aged eighty years and over. Journal of Bone and Mineral Research. 2006;21:1113–1120
  5. Palvanen M, Kannus S, Niemi S, et al. Secular trends in the osteoporotic fractures of the distal humerus in elderly women. European Journal of Epidemiology. 1998;14:159–164
  6. Cauley JA, Thompson DE, Ensrud KC, et al. Risk of mortality following clinical fractures. Osteoporosis International. 2000;11:556–561
  7. Old JL, Calvert M. Vertebral compression fractures in the elderly. American Family Physician. 2004;69:111–116
  8. Eastwood EA, Magaziner J, Hyg MS, et al. Patients with hip fracture: subgroups and their outcomes. Journal of the American Geriatrics Society. 2002;50:1240–1249
  9. Nguyen ND, Ahlborg HG, Center JR, et al. Residual lifetime risk of fractures in women and men. Journal of Bone and Mineral Research. 2007;22:781–788
  10. Dennison E, Mohamed MA, Cooper C. Epidemiology of osteoporosis. Rheumatic Diseases Clinics of North America. 2006;32:617–629
  11. Cummings SR, Melton LJ. Epidemiology and outcomes of osteoporotic fractures. Lancet. 2002;359:1761–1767
  12. Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporosis International. 2006;17:1726–1733
  13. Grados F, Marcelli C, Dargent-Molina P, et al. Prevalence of vertebral fractures in French women older than 75 years from the EPIDOS study. Bone. 2004;34:362–367
  14. Pluijm SM, Tromp AM, Smit JH, et al. Consequences of vertebral deformities in older men and women. Journal of Bone and Mineral Research. 2000;15:1564–1572
  15. Delmas PD, Marin F, Marcus R, et al. Beyond hip: importance of other nonspinal fractures. The American Journal of Medicine. 2007;120:381–387
  16. van Staa TP, Leufkens HGM, Cooper C. Does a fracture at one site predict later fractures at other sites? A British cohort study. Osteoporosis International. 2002;13:624–629
  17. Block JE, Stubbs H. Hip fracture-associated mortality reconsidered. Calcified Tissue International. 1997;61:1630–1636
  18. Bass E, French DD, Bradham DD, et al. Risk-adjusted mortality rates of elderly veterans with hip fractures. Annals of Epidemiology. 2007;17:514–519
  19. Kado DM, Browner WS, Palermo L, et al. Vertebral fractures and mortality in older women: A prospective study. Archives of Internal Medicine. 1999;159:1215–1220
  20. Kanis JA, Oden A, Johnell O, et al. Excess mortality after hospitalisation for vertebral fracture. Osteoporosis International. 2004;15:108–112
  21. Kanis JA, Johnell O, Oden A, et al. Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds. Osteoporosis International. 2001;12:989–995
  22. Boockvar KS, Halm EA, Litke A, et al. Hospital readmissions after hospital discharge for hip fracture: surgical and nonsurgical causes and effect on outcomes. Journal of the American Geriatrics Society. 2003;51:399–403
  23. Lippuner K, von Overbeck J, Perrelet R, et al. Incidence and direct medical costs of hospitalisations due to osteoporotic fractures in Switzerland. Osteoporosis International. 1997;7:414–425
  24. Randell AG, Nguyen TV, Bhalerao N, et al. Deterioration in quality of life following hip fracture: a prospective study. Osteoporosis International. 2000;11:460–466
  25. De Laet CE, van Hout BA, Burger H, et al. Bone density and risk of hip fracture in men and women: cross sectional analysis. BMJ (Clinical Research Ed.). 1997;315:221–225
  26. Ensrud KE, Duong T, Cauley JA, et al. Low fractional calcium absorption increases the risk for hip fracture in women with low calcium intake. Annals of Internal Medicine. 2000;132:345–353
  27. Boonen S, Vanderschueren D, Haentjens P, et al. Calcium and vitamin D in the prevention and treatment of osteoporosis – a clinical update. Journal of Internal Medicine. 2006;259:539–552
  28. Boonen S, Lips P, Bouillon R, et al. Need for additional calcium to reduce the risk of hip fracture with vitamin D supplementation: Evidence from a compartive metaanalysis of randomized controlled trials. The Journal of Clinical Endocrinology and Metabolism. 2007;92:1415–1423
  29. Zhu K, Devine A, Dick IM, et al. Effects of calcium and vitamin D supplementation on hip bone mineral density and calcium-related analytes in elderly ambulatory Australian women: a 5-year randomised controlled trial. Calcium and vitamin D prevents hip bone loss. The Journal of Clinical Endocrinology and Metabolism. 2008;93:743–749
  30. Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocrine Reviews. 2001;22:477–501
  31. Grant AM, Avenell A, Campbell MK, et al. Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial. Lancet. 2005;365:1621–1628
  32. Chapuy MC, Arlot ME, Duboeuf , et al. Vitamin D3 and calcium to prevent hip fractures in elderly women. The New England Journal of Medicine. 1992;327:1637–1642
  33. Chapuy MC, Arlot ME, Delmas PD, et al. Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women. BMJ (Clinical Research Ed.). 1994;308:1081–1082
  34. Chapuy MC, Pamphile R, Paris E, et al. Combined calcium and vitamin D3 supplementation in elderly women: confirmation of reversal of secondary hyperparathyroidism and hip fracture risk: the Decalyos II study. Osteoporosis International. 2002;13:257–264
  35. Porthouse J, Cockayne S, King C, et al. Randomised controlled trial of calcium and supplementation with cholecalciferol (vitamin D3) for prevention of fractures in primary care. BMJ (Clinical Research Ed.). 2005;330:1003–1008
  36. Jackson RD, La Croix AZ, Gass M, et al. Calcium plus vitamin D supplementation and the risk of fractures. The New England Journal of Medicine. 2006;354:669–683
  37. Boonen S, Bischoff-Ferrari A, Cooper C, et al. Addressing the musculoskeletal components of fracture risk with calcium and vitamin D: A review of the evidence. Calcified Tissue International. 2006;78:257–270
  38. Dawson-Hughes B, Harris SS, Krall EA, et al. Effect of withdrawal of calcium and vitamin D supplements on bone mass in elderly men and women. The American Journal of Clinical Nutrition. 2000;72:745–750
  39. Black DM. Why elderly women should be screened and treated to prevent osteoporosis. The American Journal of Medicine. 1995;98(2A):67S–75S
  40. Heaney RP. Is the paradigm shifting?. Bone. 2003;33:457–465
  41. Garnero P, Hausherr E, Chapuy MC, et al. Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study. Journal of Bone and Mineral Research. 1996;11:1531–1538
  42. Mori S, Harruff R, Ambrosius W, et al. Trabecular bone volume and microdamage accumulation in the femoral heads of women with and without femoral neck fractures. Bone. 1997;21:521–526
  43. Boonen S, McClung MR, Eastell R, et al. Safety and efficacy of risedronate in reducing fracture risk in osteoporotic women aged 80 and older: implications for the use of antiresorptive agents in the old and oldest old. Journal of the American Geriatrics Society. 2004;52:1832–1839
  44. McClung MR, Geusens P, Miller PD, et al. Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. The New England Journal of Medicine. 2001;344:333–340
  45. Hochberg MC, Thompson DE, Black DM, et al. Effec of alendronate on the age specific incidence of symptomatic osteoporotic fractures. Journal of Bone and Mineral Research. 2005;20:971–976
  46. Morin S, Rahme E, Behlouli H, et al. Effectiveness of antiresorptive agents in the prevention of recurrent hip fractures. Osteoporosis International. 2007;18:1625–1632
  47. Lyles KW, Colón-Emeric CS, Magaziner JS, et al. Zoledronic acid and clinical fractures and mortality after hip fracture. The New England Journal of Medicine. 2007;357:1799–1809
  48. Boonen SJ, Marin F, Mellstrom D, et al. Safety and efficacy of teriparatide in elderly women with established osteoporosis: bone anabolic therapy from a geriatric perspective. Journal of the American Geriatrics Society. 2006;54:782–789
  49. Manuele S, Sorbello L, Puglisi N, et al. Teriparatide in the treatment of severe senile osteoporosis. Archives of Gerontology and Geriatrics. 2007;44(Suppl 1):249–258
  50. Meunier PJ, Roux C, Seeman E, et al. The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. The New England Journal of Medicine. 2004;350:459–468
  51. Reginster JY, Seeman E, De Vernejoul MC, et al. Strontium ranelate reduces the risk of non-vertebral fractures in postmenopausal women with osteoporosis: TROPOS study. The Journal of Clinical Endocrinology and Metabolism. 2005;90:2816–2822
  52. Seeman E, Vellas B, Benhamou C, et al. Sustained 5-year vertebral and non-vertebral fracture risk reduction with strontium ranelate in elderly women with osteoporosis. Osteoporosis International. 2006;18:1–13(OC39)
  53. Reginster JY, Brixen K, Cormier C, et al. Strontium ranelate demonstrates vertebral and non-vertebral anti-fracture efficacy including hip fractures over 5 years in postmenopausal osteoporotic women. Calcified Tissue International. 2007;80(Suppl 1):S47
  54. Michaëlsson K, Baron JA, Farahmand BY, et al. Hormone replacement therapy and risk of hip fracture: population based case-control study. British Medical Journal. 1998;316:1858–1863
  55. Ettinger B, Black DM, Mitlak BH, et al. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. JAMA: The Journal of the American Medical Association. 1999;282:637–645
  56. Kannus P, Sievänen H, Palvanen M, et al. Prevention of falls and consequent injuries in elderly people. Lancet. 2005;366:1885–1893
  57. Kenny RA, Rubenstein LZ, Martin FC, et al., for the American Geriatrics Society, British Geriatrics Society and American Academy of Orthopaedic Surgeons Panel on falls prevention  Guidelines for the prevention of falls in older persons. Journal of the American Geriatrics Society. 2001;49:664–672
  58. Schwendimann R, Buhler H, De Geest S et al Characteristics of hospital in-patient falls across clinical departments. Gerontology, 2008 May 6 [Epub ahead of print].
  59. Kannus P, Niemi S, Parkkari J, et al. Perspective Why is the age-standardized incidence of low-trauma fractures rising in many elderly populations?. Journal of Bone and Mineral Research. 2002;17:1363–1367
  60. Chang JT, Morton SC, Rubenstein LZ, et al. Interventions for the prevention of falls in older adults: systematic review and meta-analysis of randomised clinical trials. BMJ (Clinical Research Ed.). 2004;328:680
  61. Gillespie LD, Gillespie WJ, Robertson MC, et al. Interventions for preventing falls in elderly people. Cochrane Database of Systematic Reviews (Online). 2003;(4):CD000340
  62. Bischoff HA, Stahelin HB, Dick , et al. Effects of vitamin D and calcium supplementation on falls: a randomized controlled trial. Journal of Bone and Mineral Research. 2003;18:343–351
  63. Gerdhem P, Ringsberg KA, Obrant KJ, et al. Association between 25-hydroxy vitamin D levels, physical activity, muscle strength and fractures in the prospective population-based OPRA Study of elderly women. Osteoporosis International. 2005;16:1425–1431
  64. Rogers ME, Rogers NL, Takeshima N, et al. Methods to assess and improve the physical parameters associated with fall risk in older adults. Preventive Medicine. 2003;36:255–264
  65. Rosenberg IH. Summary comments. The American Journal of Clinical Nutrition. 1989;50:1231–1233
  66. Deschenes MR. Effects of aging on muscle fibre type and size. Sports Medicine. 2004;34:809–824
  67. Lexell J, Henriksson-Larsen K, Winblad B, et al. Distribution of different fiber types in human skeletal muscles: effects of aging studied in whole muscle cross sections. Muscle & Nerve. 1983;6:588–595
  68. Doherty TJ. Invited review: aging and sarcopenia. Journal of Applied Physiology. 2003;95:1717–1727
  69. Sipilä S, Suominen H. Effects of strength and endurance training on thigh and leg muscle mass and composition in elderly women. Journal of Applied Physiology. 2005;78:334–340
  70. Frontera WR, Meredith CN, O'Reilly KP, et al. Strength conditioning in older men: skeletal muscle hypertrophy and improved function. Journal of Applied Physiology. 1988;64:1038–1044
  71. Fielding RA. The role of progressive resistance training and nutrition in the preservation of lean body mass in the elderly. Journal of the American College of Nutrition. 1995;14:587–594
  72. Hagerman FC, Walsh SJ, Staron RS, et al. Effects of high-intensity resistance training on untrained older men. I. Strength, cardiovascular, and metabolic responses. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences. 2000;55:B336–B346
  73. Burke D, Schiller HH. Discharge pattern of single motor units in the tonic vibration reflex of human triceps surae. Journal of Neurology, Neurosurgery, and Psychiatry. 1976;39:729–741
  74. Hagbarth KE, Eklund G. Tonic vibration reflexes (TVR) in spasticity. Brain Research. 1966;2:201–203
  75. Delecluse C, Roelants M, Verschueren S. Strength increase after whole-body vibration compared with resistance training. Medicine and Science in Sports and Exercise. 2003;35:1033–1041
  76. Roelants M, Delecluse C, Verschueren SM. Whole-body-vibration training increases knee-extension strength and speed of movement in older women. Journal of the American Geriatrics Society. 2004;52:901–908
  77. Torvinen S, Kannus P, Sievanen H, et al. Effect of four-month vertical whole body vibration on performance and balance. Medicine and Science in Sports and Exercise. 2002;34:1523–1528
  78. Bogaerts A, Delecluse C, Claessens AL, et al. Impact of whole-body vibration training versus fitness training on muscle strength and muscle mass in older men: a 1-year randomized controlled trial. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences. 2007;62:630–635
  79. Horak FB, Shupert CL, Mirka A. Components of postural dyscontrol in the elderly: a review. Neurobiology of Aging. 1989;10:727–738
  80. Judge JO, Lindsey C, Underwood M, et al. Balance improvements in older women: effects of exercise training. Physical Therapy. 1993;73:254–262
  81. Shumway-Cook A, Gruber W, Baldwin M, et al. The effect of multidimensional exercises on balance, mobility, and fall risk in community-dwelling older adults. Physical Therapy. 1997;77:46–57
  82. Gillespie L. Preventing falls in elderly people. BMJ (Clinical Research Ed.). 2004;328:653–654
  83. Robertson MC, Campbell AJ, Gardner MM, et al. Preventing injuries in older people by preventing falls: a meta-analysis of individual-level data. Journal of the American Geriatrics Society. 2002;50:905–911
  84. Li F, Harmer P, Fisher KJ, et al. Tai chi and fall reductions in older adults: a randomized controlled trial. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences. 2005;60:187–194
  85. Duncan CS, Blimkie CJ, Cowell CT, et al. Bone mineral density in adolescent female athletes: relationship to exercise type and muscle strength. Medicine and Science in Sports and Exercise. 2002;34:286–294
  86. Rubin CT, Lanyon LE. Regulation of bone mass by mechanical strain magnitude. Calcified Tissue International. 1985;37:411–417
  87. Rubin CT, Sommerfeldt DW, Judex S, et al. Inhibition of osteopenia by low magnitude, high-frequency mechanical stimuli. Drug Discovery Today. 2001;16:848–858
  88. Lanyon LE. Using functional loading to influence bone mass and architecture: Objectives, mechanisms, and relationship with estrogen of the mechanically adaptive process in bone. Bone. 1996;18:37S–43S
  89. Rubin J, Murphy T, Nanes MS, et al. Mechanical strain inhibits expression of osteoclast differentiation factor by murine stromal cells. American Journal of Physiology. Cell Physiology. 2000;278:C1126–C1132
  90. Shibata Y, Ohsawa I, Watanabe T, et al. Effects of physical training on bone mineral density and bone metabolism. Journal of Physiological Anthropology and Applied Human Science. 2003;22:203–208
  91. Kato T, Terashima T, Yamashita T, et al. Effect of low-repetition jump training on bone mineral density in young women. Journal of Applied Physiology. 2006;100:839–843
  92. Vainionpää A, Korpelainen R, Leppäluoto J, et al. Effects of high-impact exercise on bone mineral density: a randomized controlled trial in premenopausal women. Osteoporosis International. 2005;16:191–197
  93. Kontulainen S, Heinonen A, Kannus P, et al. Former exercisers of an 18-month intervention display residual aBMD benefits compared with control women 3,5 years post-intervention: a follow-up of a randomized controlled high-impact trial. Osteoporosis International. 2004;15:248–251
  94. Xei L, Jacobson JM, Choi ES, et al. Low-level mechanical vibrations can influence bone resorption and bone formation in the growing skeleton. Bone. 2006;39:1059–1066
  95. Verschueren SM, Roelants M, Delecluse C, et al. Effect of 6-month whole body vibration training on hip density, muscle strength, and postural control in postmenopausal women, a randomized controlled pilot study. Journal of Bone and Mineral Research. 2004;19:352–359
  96. Campbell AJ, Robertson MC, Gardner MM, et al. Psychotropic medicine withdrawal and a home-based exercise program to prevent falls: a randomized controlled trial. Journal of the American Geriatrics Society. 1999;47:850–853
  97. Kenny RA, Richardson DA, Steen N, et al. Carotid sinus syndrome: a modifiable risk factor for nonaccidental falls in older adults (SAFE PACE). Journal of the American College of Cardiology. 2001;38:1491–1496
  98. Harwood RH, Foss AJ, Osborn F, et al. Falls and health status in elderly women following first eye cataract surgery: a randomised controlled trial. The British Journal of Ophthalmology. 2005;89:53–59
  99. Gates S, Fisher JD, Cooke MW, et al. Multifactorial assessment and targeted intervention for preventing falls and injuries among older people in community and emergency care settings: systematic review and meta-analysis. BMJ (Clinical Research Ed.). 2008;336:130–133
  100. Lamb SE, Jørstad-Stein EC, Hauer K, et al. Development of a common outcome data set for fall injury prevention trials: the Prevention of Falls Network Europe Consensus. Journal of the American Geriatrics Society. 2005;53:1618–1622
  101. Milisen K, Geeraerts A & Dejaeger E. Use of a fall-prevention practice guideline for community-dwelling older persons at risk for falling: a feasibility study. Gerontology, in press.
  102. Yardley L, Beyer N, Hauer K. Recommendations for promoting the engagement of older people in activities to prevent falls. Quality & Safety in Health Care. 2007;16:230–234
  103. Oliver D, Connelly JB, Victor CR, et al. Strategies to prevent falls and fractures in hospitals and care homes and effect of cognitive impairment: Systematic review and meta-analyses. BMJ (Clinical Research Ed.). 2007;334:82–87
  104. Coussement J, De Paepe L, Schwendimann R, et al. Interventions for preventing falls in acute- and chronic-care hospitals: a systematic review and meta-analysis. Journal of the American Geriatrics Society. 2008;56:29–36
  105. Cumming RG, Sherrington C, Lord SR, et al. Cluster randomised trial of a targeted multifactorial intervention to prevent falls among older people in hospital. BMJ (Clinical Research Ed.). 2008;336:758–760
  106. Cusimano MD, Kwok J, Spadafora K. Effectiveness of multifaceted fall-prevention programs for the elderly in residential care. Injury Prevention. 2008;14:113–122
  107. van Schoor NM, Smit JH, Bouter LM, et al. Maximum potential preventive effect of hip protectors. Journal of the American Geriatrics Society. 2007;55:507–510
  108. van Schoor NM, Deville WL, Bouter LM, et al. Acceptance and compliance with external hip protectors: a systematic review of the literature. Osteoporosis International. 2002;13:917–924
  109. Kannus P, Parkkari J. Prevention of hip fracture with hip protectors. Age and Ageing. 2006;35–S2:ii51–ii54
  110. Poole KES, Reeve J, Warburton EA. Falls, fractures, and osteoporosis after stroke: time to think about protection?. Stroke. 2002;33:1432–1436
  111. Kanis J, Oden A, Johnell O. Acute and long-term increase in fracture risk after hospitalization for stroke. Stroke. 2001;32:702–706
  112. Ramnemark A, Nyberg L, Borssén B, et al. Fractures after stroke. Osteoporosis International. 1998;8:92–95
  113. Eastell R, Reid DM, Compston J, et al. A UK consensus group on management of glucocorticoid-induced osteoporosis: an update. Journal of Internal Medicine. 1998;244:271–292
  114. van Staa TP, Leufkens M, Cooper C. The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporosis International. 2002;13:777–787
  115. Woolf AD, Åkesson K. Preventing fracture in elderly people. BMJ (Clinical Research Ed.). 2003;327:89–95
  116. Delmas PD, Rizzoli R, Cooper C, et al. Treatment of patients with postmenopausal osteoporosis is worthwhile. The position of the International Osteoporosis Foundation. Osteoporosis International. 2005;16:1–5
  117. Fleurence RL, Iglesias CP, Johnson JM. The cost effectiveness of bisphosphonates for the prevention and treatment of osteoporosis: a structured review of the literature. Pharmacoeconomics. 2007;25:913–933
  118. Schousboe JT, Taylor BC, Fink HA, et al. Cost-effectiveness of bone densitometry followed by treatment of osteoporosis in older men. JAMA: The Journal of the American Medical Association. 2007;298:629–637
  119. Perreault S, Dragomir A, Desgagné A, et al. Trends and determinants of antiresorptive drug use for osteoporosis among elderly women. Pharmacoepidemiology and Drug Safety. 2005;14:685–695
  120. Papaioannou A, Kennedy CC, Ioannidis G, et al. The osteoporosis care gap in men with fragility fractures: the Canadian Multicentre Osteoporosis Study. Osteoporosis International. 2008;19:581–587
  121. National Osteoporosis Society . Primary care strategy for osteoporosis and falls. Bath: National Osteoporosis Society; 2002;
  122. Solomon DH, Avorn J, Katz JN, et al. Compliance with osteoporosis medications. Archives of Internal Medicine. 2005;165:2414–2419
  123. Seeman E, Compston J, Adachi J, et al. Non-compliance: the Achilles' heel of anti-fracture efficacy. Osteoporosis International. 2007;18:711–719
  124. Clowes JA, Peel NF, Eastell R. The impact of monitoring on adherence and persistence with antiresorptive treatment for postmenopausal osteoporosis: a randomised controlled trial. The Journal of Clinical Endocrinology and Metabolism. 2004;89:1117–1123
  125. Pfeifer M, Sinaki M, Guesens P, et al., on behalf of the ASBMR Working Group on Musculoskeletal Rehabilitation  Musculoskeletal rehabilitation in osteoporosis. A review. Journal of Bone and Mineral Research. 2004;19:1208–1214

PII: S1521-690X(08)00080-8

doi: 10.1016/j.beem.2008.07.002

Best Practice & Research Clinical Endocrinology & Metabolism
Volume 22, Issue 5 , Pages 765-785 , October 2008

Article Tools

* Image Usage & Resolution